Get started
AMC Entertainment Holdings | AMC | Long at $3.66First, I'm not an " NYSE:AMC APE" and have zero interest in becoming one. Second, don't trade NYSE:AMC unless you are fully aware the investment could go to zero or the company may devalue your trade via share dilution or other means (i.e., don't simply do as I do or blindly follow anyone else's moves, for the matter). With that aside, I started a position/gambling play today in NYSE:AMC at $3.66. The reason is 80% technical analysis and 20% fundamentals. Technical Analysis: The blue line on the chart represents an average true range (ATR) from a historical simple moving average (SMA) that I use for trading. For simplicity, the historical SMA is not show on the chart - just the ATR. This blue ATR line has historically been a major line of resistance and support. When it breaks through and holds, the stock goes bull - but history may not repeat. The price recently broke the blue ATR line, fell below, and the broke out again today. This may be a sign that the downward trend (overall) is changing - perhaps furthering the accumulation phase in the $3s or a gradual rise from here. And with today's breakout, I grabbed shares at $3.66. Fundamentals Since 2020, NYSE:AMC has shown major gains in revenue and net income (loss reduction, that is). Revenu: $1.24 billion (2020); $2.53 billion (2021); $3.91 billion (2022); 4.81 billion (2023); $4.4 billion (2024, Q1-3 only). Net Income: -$4.5 billion (2020); -$1.27 billion (2021); -$973 million (2022); -$396 million (2023); -$399 million (2024, Q1-3 only). The company is not expected to become profitable until Q4 of 2026 , but the improvements are what one would like to see. Counter-arguments and statements the stock is junk are totally valid. But the chart is quite interesting as the company moves toward profitability (maybe...). Targets: $4.30 $6.00 Squeeze/mass hysteria: $18.00, $40.00, and ridiculousness: $85.00
NYSE:AMCLong
by WorthlessViews
5
SUTM LONG TRADE (TEXTILE SECTOR) 12-06-2025- SUTM was previously in a huge downtrend till May 2023, followed by an accumulation zone until April this year. - The stock broke out of this accumulation zone in a powerful manner with strong volume, touching a high of 249. - After the breakout, the stock entered a corrective channel (marked in yellow) and formed a bull flag. - Today, the stock broke up from this bull flag, indicating a continuation of the uptrend. 🚨 TECHNICAL BUY CALL – SUTM🚨 - BUY1: 203.68 - BUY2: 196 - BUY3: 186 - BUY4: 176 Target Prices - TP1: 222.21 - TP2: 236 - TP3: 252 - TP4: 261 Stop loss: 160 DAILY CLOSE RISK: REWARD - 1:3.75 Caution: Close at least 50% position size at TP1 and then trail SL to avoid losing incurred profits in case of unforeseen market conditions. PLEASE BOOST AND SHARE THE IDEA IF YOU FIND IT HELPFUL.
PSX:SUTMLong
by Mushtaque77
6/6/25 - $anf - Upgrading this to a buy ~$806/6/25 :: VROCKSTAR :: NYSE:ANF Upgrading this to a buy ~$80 - low teens fcf yield - single digit PE - brand healthy and growing - stock beat/ stock ripped - company buying back shares - when i compare to something like $lulu... i think... this name is already priced for recession and anything lower here beyond a degradation of the brand itself is getting greedy for the right reasons. on the topic of NASDAQ:LULU (which i commented on this AM as well post EPS)... you have to be more careful on entry, even tho let's also agree... the brand is defn stronger... but 3x better (px-valuation-wise)? well that's for u to consider be well. might consider getting long this, in small size today V
NYSE:ANFLong
by VROCKSTAR
2
ADM 1D: 10-Month Channel Says Goodbye?Since July 18, 2024, ADM had been locked in a clean downward channel — well-behaved, well-respected. But in May 2025, the structure finally cracked: price broke out, crossed above the 50-day MA, and pulled back for a textbook retest right on the channel’s upper edge. So far, the breakout is holding. The next targets sit at 50.6 (0.618), 53.5 (0.5), and 56.5 (0.382). As long as price stays outside the channel, the bullish structure remains intact. Connor’s RSI down below is quietly doing its job — already bounced from deep oversold, now curling up with momentum. It’s not flashy, but in this context it signals early strength before the crowd notices. Fundamentally, ADM is still cleaning up after the early-2024 accounting scandal that nuked investor trust. But management moved fast: reinstated buybacks, tightened guidance, and Q1 2025 came in strong — $22.6B revenue, $0.88 EPS, both beating expectations. ADM remains a pillar of the U.S. ag sector, and in an era of global food anxiety, that means structural demand isn’t going anywhere. Вот адаптированный перевод финального блока под **английский пост**, в том же живом и профессиональном стиле: Enjoyed the idea? Like, share, and drop your thoughts in the comments. It helps keep the content visible, free, and accessible to everyone. Got your own charts or takes? Let’s discuss them below.
NYSE:ADMLong
by TotoshkaTrades
BIPL LONG TRADE 05-06-2025BIPL has been trading in a channel since March 2024, with a range of PKR 20 to PKR 26.1. Recently, the stock made a sharp downward move in the form of a spring, quickly returning within the range, indicating a potential reversal or upward action. The stock has formed a reversal pattern in the shape of an inverted head and shoulders pattern, with adequate volume distribution and price action in a spike fashion, suggesting an upward move is likely. However, buying at the current level of PKR 23.15 is not recommended. Instead, we suggest waiting for a pullback to the demand zone that caused the upward move, which lies between PKR 22.3 and PKR 21.4. 🚨 TECHNICAL BUY CALL – BIPL🚨 - Buy 1: PKR 22.3 - Buy 2: PKR 21.4 TP1: PKR 24.7 TP2: PKR 26 stop Loss: Below PKR 20 (DAILY closing) Risk-Reward Ratio: 1:3.37
PSX:BIPLLong
by Mushtaque77
1
ASHT LONG TRADE 09-06-2025ASHT LONG TRADE After reversing from its downtrend in June 2022, ASHT entered an uptrend. Since July 2024, it has been trading in a range between PKR 11 and PKR 17.6. Currently, it's poised for a potential breakout, having formed a strong flipped institutional demand zone, which acts as a preventive barrier against downward movements. The volume profile also supports an impending up move. 🚨 TECHNICAL BUY CALL – ASHT🚨 - Buy 1: PKR 17.55 (current level) - Buy 2: PKR 16.7 - Buy 3: PKR 15.7 - TP1: PKR 19.6 - TP2: PKR 21.4 - TP3: PKR 24.00 *Stop Loss:* Below PKR 14.7 - Daily Close *Risk-Reward Ratio:* 1:2.35 Caution: Please buy in 3 parts in buying range. Close at least 50% position size at TP1 and then trail SL to avoid losing incurred profits in case of unforeseen market conditions. PLEASE BOOST AND SHARE THE IDEA IF YOU FIND IT HELPFUL.
PSX:ASHTLong
by Mushtaque77
Where is HIMS set to go next?Overview of Hims & Hers Health (NYSE: HIMS): Pros Expanding into weight-loss treatments -Hims successfully entered the high-demand GLP‑1 weight-loss space by selling compounded semaglutide during shortages. With branded Wegovy now available on their platform in partnership with Novo Nordisk, they’ve broadened their offering. Solid growth & rising profitability -Revenue surged ~18% in 2024 to $1.78 b ttm, with annual net income of $164 m. -Q1 2025 reported >100% YoY revenue growth ($586 m) with expected profit of 20¢/share. Strong gross margins -At around 80–88%, comparable to peer telehealth platforms. Diverse healthcare offerings -Beyond weight loss: sexual health, skincare, hair loss, mental health via DTC model. Expanded further via European acquisition of ZAVA (~1.3 m subscribers). Undervalued relative to future earnings -Analysts project 2030 revenues of $6.5 b—implying mid‑20s% CAGR. With projected EPS ~$1.5 b, current multiples (P/E ~40x) might look reasonable long term. Cons GLP‑1 strategy under pressure -The end of compounding allowances by FDA reduced their low-cost advantage. -Dependence on cash-pay vs. insurer coverage may limit growth if insurers cap co-pays. High valuation with risk -Trading at ~84x trailing EPS and ~70x forward EPS—wide margin for missteps. -Analysts average target at $38 (≈ 33% downside), 12 rate it a 'Hold'. Competitive & regulatory headwinds -Market crowded with telehealth players like Ro, Noom, CVS, and insurers which may undercut cash-pay model. -Legal scrutiny over “personalized” compounded products persists; Novo lawsuits underway. Reputation & controversy -CEO’s political donation stirred backlash; regulatory scrutiny around ads and compounding practices. -Platform has faced occasional service and customer trust issues. -Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial advice, investment recommendation, or an offer to buy or sell any securities. Stock prices, valuations, and performance metrics are subject to change and may be outdated. Always conduct your own due diligence and consult with a licensed financial advisor before making investment decisions. The information presented may contain inaccuracies and should not be solely relied upon for financial decisions. I am not personally liable for your own losses, this is not financial advise.
NYSE:HIMS
by bossout10
1
Meta Platforms - This stock tastes sooo good!Meta Platforms - NASDAQ:META - will print a new all time high: (click chart above to see the in depth analysis👆🏻) Over the course of the past two months, Meta has been rallying +40%. This recent behaviour was not unexpected at all but rather the consequence of the all time high break and retest. Now - back at the previous all time high - Meta will most likely break out higher again. Levels to watch: $700, $900 Keep your long term vision! Philip (BasicTrading)
NASDAQ:METALong
by basictradingtv
4
PECO LONG TRADE & INVESTMENT CALL 06-06-2025PECO LONG TRADE & INVESTMENT CALL PECO has been in an uptrend since May 2020, comprising Elliott Waves. After completing impulse waves 1 and 3, and corrective wave 2, the stock recently completed a complex corrective wave 4. Now, it's poised to start its final impulse wave 5. The reversal from corrective wave 4 to impulse wave 5 has formed an inverted head and shoulders pattern. Wave 4 ended between the 50% to 61.8% Fibonacci retracement levels. 🚨 TECHNICAL BUY CALL – PECO🚨 - Buy 1: PKR 781.3 (current level) - Buy 2: PKR 750 - Buy 3: PKR 725 - TP1: PKR 860 - TP2: PKR 928 - TP3: PKR 978 - TP4: PKR 1039 LONGTERM - TP5: PKR 1108 LONGTERM - TP6: PKR 1176 LONGTERM STOPLOSS BELOW PKR 700 CLOSING BASIS Risk-Reward Ratio: 1:5.8 Caution: Close at least 50% position size at TP1 and then trail SL to avoid losing incurred profits in case of unforeseen market conditions. PLEASE BOOST AND SHARE THE IDEA IF YOU FIND IT HELPFUL.
PSX:PECOLong
by Mushtaque77
California Resources Corporation (CRC) – Stock Analysis and ForeCalifornia Resources Corporation, a key player in crude oil production and carbon management, has recently experienced a notable uptick in investor interest. This momentum appears to be supported by macroeconomic tailwinds, including renewed trade tensions between the United States and other major economies. Historically, geopolitical uncertainty often leads to increased energy demand and price volatility, both of which tend to benefit domestic oil producers like CRC. From a fundamental standpoint, investor sentiment toward CRC has grown increasingly positive. The company’s strategic positioning in California's energy transition—particularly its focus on carbon capture and storage (CCS)—is beginning to resonate more with institutional investors looking to align portfolios with sustainable yet profitable energy operations. If these supportive fundamentals continue, there is potential for the stock to reach $56 in the coming months, assuming no major changes to current market dynamics or geopolitical influences. Technical Outlook: Entry Point: $44.68 Stop Loss: $42.73 Take Profit 1: $50.84 Take Profit 2: $55.88 As always, trade with care, apply proper risk management, and ensure your positions align with your overall investment strategy. If you find this helpful, kindly follow me, subscribe, like, comment and share.
NYSE:CRCLong
by ForexClinik
2